The outcome and related risk factors of unvaccinated patients with end-stage kidney disease during the Omicron pandemic: a multicentre retrospective study

Author:

Zhang Quanchao,Lu Caibao,Wu Shaofa,He Jin,Wang Han,Li Jie,Wu Zhifen,Tang Bingshuang,Yang Bingfeng,Liao Shengli,Wang Liao,Chen Hongwei,Li Moqi,He Wenchang,Wang Yiqin,Jiang Lili,Zhao Jing-Hong,Nie LingORCID

Abstract

ObjectivesThe study aims to identify the outcome and the related factors of unvaccinated patients with end-stage kidney disease during the Omicron pandemic.DesignA multicentre retrospective study of patients with end-stage kidney disease undergone maintenance haemodialysis (HD) in China.Setting6 HD centres in China.ParticipantsA total of 654 HD patients who tested positive for SARS-CoV-2 were ultimately included in the study.Outcome measuresThe primary outcomes of interest were adverse outcomes, including hospitalisation due to COVID-19 and all-cause mortality.ResultsThe average age of the patients was 57 years, with 33.6% of them being over 65 years. Among the patients, 57.5% were male. During the follow-up period, 158 patients (24.2%) experienced adverse outcomes, and 93 patients (14.2%) died. The majority of patients (88/158) developed adverse outcomes within 30 days, and most deaths (77/93) occurred within 1 month. An advanced multivariable Cox regression analysis identified that adverse outcomes were associated with various factors while all-cause mortality was related to advanced age, male gender, high levels of C reactive protein (CRP) and low levels of prealbumin. The Kaplan-Meier curves demonstrated significantly higher all-cause mortality rates in the older, male, high CRP and low prealbumin subgroups.ConclusionsAmong unvaccinated HD patients with confirmed Omicron infections, various factors were found to be linked to adverse outcomes. Notably, age, sex, CRP and prealbumin had a substantial impact on the risk of all-cause mortality.

Funder

National Natural Science Foundation of China

Publisher

BMJ

Reference31 articles.

1. WHO2 . World Health Organization; 2022. Available: https://covid19.who.int/

2. Antibody Seroprevalence in the epicenter Wuhan, Hubei, and six selected provinces after containment of the first epidemic wave of COVID-19 in China;Li;Lancet Reg Health West Pac,2021

3. Angiotensin-converting enzyme 2 in the pathogenesis of renal abnormalities observed in COVID-19 patients;Azinheira Nobrega Cruz;Front Physiol,2021

4. Kidney disease is associated with in-hospital death of patients with COVID-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3